NCT07084116View on ClinicalTrials.gov

Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

February 1, 2026

Conditions
Skin TearSolar PurpuraDermatoporosis
Interventions
DRUG

Tretinoin 0.1% cream

Tretinoin 0.1% cream formulation.

DRUG

Bland cream (non-drug)

Bland cream formulation.

Trial Locations (1)

94304

Palo Alto VA Medical Center, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER